Meta-Analysis
Copyright ©The Author(s) 2017.
World J Transplant. Apr 24, 2017; 7(2): 152-160
Published online Apr 24, 2017. doi: 10.5500/wjt.v7.i2.152
Table 2 Quality assessment items and possible scores
Was the assigned treatment adequately concealed prior to allocation?
2 = method did not allow disclosure of assignment
1 = small but possible chance of disclosure of assignment or unclear
0 = quasi-randomized or open list/tables
Were the outcomes of participants who withdrew described and included in the analysis (intention-to-treat)?
2 = withdrawals well described and accounted for in analysis
1 = withdrawals described and analysis not possible
0 = no mention, inadequate mention, or obvious differences and no adjustment
Were the outcome assessors blinded to treatment status?
2 = effective action taken to blind assessors
1 = small or moderate chance of unblinding of assessors
0 = not mentioned or not possible
Were the treatment and control groups comparable at entry? (likely confounders may be age, partial or total rupture, activity level, acute or chronic injury)
2 = good comparability of groups, or confounding adjusted for in analysis
1 = confounding small; mentioned but not adjusted for
0 = large potential for confounding, or not discussed
Were the participants blind to assignment status after allocation?
2 = effective action taken to blind participants
1 = small or moderate chance of unblinding of participants
0 = not possible, or not mentioned (unless double-blind), or possible but not done
Were the treatment providers blind to assignment status?
2 = effective action taken to blind treatment providers
1 = small or moderate chance of unblinding of treatment providers
0 = not possible, or not mentioned (unless double-blind), or possible but not done
Were care programes, other than the trial options, identical?
2 = care programes clearly identical
1 = clear but trivial differences
0 = not mentioned or clear and important differences in care programes
Were the inclusion and exclusion criteria clearly defined?
2 = clearly defined
1 = inadequately defined
0 = not defined
Were the interventions clearly defined?
2 = clearly defined interventions are applied with a standardized protocol
1 = clearly defined interventions are applied but the application protocol is not standardized
0 = intervention and/or application protocol are poorly or not defined
Were the outcome measures used clearly defined? (by outcome)
2 = clearly defined
1 = inadequately defined
0 = not defined
Were diagnostic tests used in outcome assessment clinically useful? (by outcome)
2 = optimal
1 = adequate
0 = not defined, not adequate
Was the surveillance active, and of clinically appropriate duration?
2 = active surveillance and appropriate duration
1 = active surveillance, but inadequate duration
0 = surveillance not active or not defined